Forward P/S Multiple: Xtant Medical Holdings, Inc. (XTNT)

Xtant Medical Holdings generates revenue by developing orthopedic instruments and bone grafts. The expected price-to-sales ratio reflects market expectations, with the parameter stabilizing at 0.30. Steady demand for spinal surgeries ensures a consistent cash flow. Supply chain security is guaranteed by strict certification of external contractors, which minimizes dependency risks on specific vendors.
Summary analytical data breakdowns for Xtant Medical (XTNT)

For Xtant Medical (XTNT), whose positions in the spinal implant segment are protected by patents and hospital contracts, the forward P/S multiple serves as an indicator of market confidence in future sales. This metric is calculated as the ratio of current market capitalization to expected annual revenue, allowing investors to value each dollar of future income and determine capital stability amid bond volatility.